|
Report Date : |
30.10.2012 |
IDENTIFICATION DETAILS
|
Name : |
INSTITUTO TERAPEUTICO DELTA LTDA |
|
|
Registered Office : |
Estrada |
|
|
|
|
|
|
Country : |
|
|
|
|
|
|
|
Date of Incorporation : |
13.06.1947 |
|
|
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
|
|
Line of Business : |
Manufacture of Pharmaceuticals. |
|
|
|
|
|
|
No. of Employees : |
200 |
|
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2011) |
Current Rating (30.06.2012) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
BRAZIL - ECONOMIC OVERVIEW
Characterized by large and
well-developed agricultural, mining, manufacturing, and service sectors,
Brazil's economy outweighs that of all other South American countries, and
Brazil is expanding its presence in world markets. Since 2003, Brazil has
steadily improved its macroeconomic stability, building up foreign reserves,
and reducing its debt profile by shifting its debt burden toward real
denominated and domestically held instruments. In 2008, Brazil became a net
external creditor and two ratings agencies awarded investment grade status to
its debt. After strong growth in 2007 and 2008, the onset of the global
financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession,
as global demand for Brazil's commodity-based exports dwindled and external
credit dried up. However, Brazil was one of the first emerging markets to begin
a recovery. In 2010, consumer and investor confidence revived and GDP growth
reached 7.5%, the highest growth rate in the past 25 years. Rising inflation
led the authorities to take measures to cool the economy; these actions and the
deteriorating international economic situation slowed growth to 2.7% for 2011
as a whole, though forecasts for 2012 growth are somewhat higher. Despite
slower growth in 2011, Brazil overtook the United Kingdom as the world's
seventh largest economy in terms of GDP. Urban unemployment is at the historic
low of 4.7% (December 2011), and Brazil's traditionally high level of income
equality has declined for each of the last 12 years. Brazil's high interest
rates make it an attractive destination for foreign investors. Large capital
inflows over the past several years have contributed to the appreciation of the
currency, hurting the competitiveness of Brazilian manufacturing and leading
the government to intervene in foreign exchanges markets and raise taxes on
some foreign capital inflows. President Dilma ROUSSEFF has retained the
previous administration's commitment to inflation targeting by the central
bank, a floating exchange rate, and fiscal restraint.
Source : CIA
INSTITUTO
TERAPEUTICO DELTA LTDA
|
MAIN ADDRESS: |
ESTRADA ALAMEDA CAPOVILLA,129 - RECREIO CAMPESTRE |
|
ZIP CODE/CITY: |
13347-310 - INDAIATUBA/SP |
|
|
|
|
PHONE: |
19 3801-8900 |
|
FAX: |
19 3801-8900 |
|
E-MAIL: |
maria.lima@labdelta.com.br |
|
WEB SITE: |
www.labdelta.com.br |
|
BRANCHES: |
|
NOT AVAILABLE. |
|
MAIN ACTIVITIES: |
|
MANUFACTURE OF PHARMACEUTICALS. |
|
LEGAL FORM: |
LIMITED
LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
13/06/1947 |
|
REGISTER DATE: |
13/06/1947 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
33.173.097/0001-93 |
|
STATE REGISTER: |
110.315.609.119 |
|
|
|
|
SHARE CAPITAL: |
R$ 98.790.563,00 |
|
LAST REGISTER OF CAPITAL: |
04/05/2012 |
|
BOARD OF
DIRECTORS: |
|
|
|
|
|
CARLOS ALBERTO PICOSSE |
MANAGING PARTNER |
|
PHILIP WALDENLOBERG JR |
MANAGER |
|
THE MANAGERS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
VALEANT FARMACÊUTICA DO BRASIL LTDA |
R$ 98.790.562,00 |
|
CARLOS ALBERTO PICOSSE |
R$ 1,00 |
|
AFFILIATES / SUBSIDIARIES |
|
|
|
|
|
A SCAN THROUGH OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR DIRECTORS HAS
THE FOLLOWING UNCONFIRMED HOLDINGS: |
|
|
|
|
|
FARMERVILLE PARTICIPAÇÕES LTDA. |
|
|
CALABAR PARTICIPAÇÕES LTDA. |
|
|
BUNKER INDUSTRIA FARMACEUTICA LTDA |
|
|
RECOPHAR COMERCIO E REPRESENTAÇÕES LTDA. |
|
|
THE SUBJECT WAS ESTABLISHED ON JUNE 13, 1947 TO BE ENGAGED IN THE SAID
LINE OF BUSINESS AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL
SCENE REPORTED HEREIN. THE COMPANY OPERATES WITH THE TRADE NAME "LABORATÓRIO
DELTA". ON FEBRUARY 03, 2011 THE COMPANY TOOK OVER CALABAR PARTICIPAÇÕES LTDA. PARTNERS: VALEANT FARMACÊUTICA DO BRASIL LTDA: REGISTRATION NIRE 35.202.716.120,
HEADQUARTERED AT RUA MARIO JUNQUEIRA DA SILVA, 736/766, JARDIM EULINA, ZIP
CODE 13063-000, CAMPINAS/SP; CARLOS ALBERTO PICOSSE: BRAZILIAN, HOLDER OF DOCUMENTS CPF
063.118.658-15, RG 3037289, RESIDENTIAL ADDRESS AT RUA GERALDO FLAUSINO
GOMES, 61, 10º ANDAR, MONÇÕES, ZIP CODE 04575-060, SÃO PAULO/SP, REPRESENTING
CALABAR PARTICIPAÇÕES LTDA AND VALEANT FARMACÊUTICA DO BRASIL LTDA. FURTHER DETAILS ARE SO FAR NOT KNOWN. REMARKS: -------- WHEN CONTACTING THE SUBJECT WE INTERVIEWED MS. MARIA, FINANCIAL
DEPARTMENT, WHO INFORMED THAT WOULD NOT DISCLOSE ANY KIND OF INFORMATION
UNLESS THE INQUIRING PARTY'S NAME WAS DISCLOSED. IF IT IS POSSIBLE TO DISCLOSE THE NAME OF THE INTERESTED SUPPLIER OF
THE SUBJECT, WE MAY RESUME OUR CONTACTS AND TRY TO OBTAIN FURTHER
INFORMATION. THE DATA CONTAINED HEREIN WERE OBTAINED FROM OUTSIDE SOURCES, OUR
DATABASE AND OFFICIAL. NO FURTHER DATA WAS AVAILABLE WITH SEVERAL SOURCES
USUALLY INVESTIGATED. |
|
PUBLIC INFORMATION: |
|
NO DETRIMENTAL FILES WERE FOUND. |
|
THE SUBJECT FILES THE ACCOUNTS THROUGH AN ACCOUNTANCY PROCEEDING NAMED
"LUCRO PRESUMIDO" (PRESUMED PROFIT) WHICH EXEMPTS IT OF BUILDING UP
BALANCE SHEET OR ANY OTHER BOOKING PROCEEDINGS WHICH ARE USUAL FOR COMPANIES WHICH
FILE ACCOUNTS THROUGH THE ACCOUNTANCY PROCEEDING NAMED "LUCRO REAL"
(REAL PROFIT). WHEN INTERVIEWED THE SOURCES AT THE SUBJECT WE WERE INFORMED THAT THEY
WOULD NOT PROVIDE ANY FINANCIAL FIGURE PER POLICY. OUTSIDE SOURCES CONTACTED SHOWED THE FOLLOWING DATA ABOUT THIS
COMPANY: 2003 TOTAL SALES: R$ 18.172.032,11 2004 TOTAL SALES: R$ 23.758.401,04 |
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 2,02 |
- OFFICIAL RATE ON 26/10/2012 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
IN THE ABSENCE OF BALANCE SHEET INFORMATION NO COMMENTS CAN BE MADE
ABOUT THE SUBJECT'S CURRENT FINANCIAL STANDING. ACCORDING TO THE RULES OF THE ACCOUNTANCY PROCEEDING FOLLOWED BY THE
SUBJECT, IT COLLECTS THE TAXES, WHICH ARE DUE OVER THE GROSS SALES AMOUNT.
THE TAXES SHOULD BE COLLECTED EITHER WITH PROFIT OR LOSS AT THE END OF THE
FISCAL YEAR. REGARDING THE RULES OF THE ABOVE SAID PROCEEDING IT MAY BE POSSIBLE TO
STATE THAT COMPANIES WHICH FILE ACCOUNTS THROUGH THIS PROCEEDING ARE
PROFITABLE COMPANIES. IT IS STATED BECAUSE THE MAIN DIFFERENCE OF THE
PROCEEDING NAMED "LUCRO REAL" AND THE ONE NAMED "LUCRO
PRESUMIDO" IS THAT IN THE FIRST THE COMPANY ONLY PAYS INCOME TAX WHEN IT
HAS PROFIT AT THE END OF THE FISCAL YEAR, WHILE IN THE LAST THE COMPANY PAYS
INCOME TAX REGARDLESS IT HAS PROFIT OR LOSS. THEREFORE, IF ANY COMPANY WHICH
ADOPTS THE "PRESUMED PROFIT" PROCEEDING WAS NOT PROFITABLE IT WOULD
BE A BETTER OPTION TO FILE ACCOUNTS THROUGH THE "LUCRO REAL"
PROCEEDING BECAUSE IN THIS PROCEEDING TAXES ARE DUE ONLY WHEN PROFITABLE
RESULTS ARE MET. IN CASE OF LOSSES NO INCOME TAX IS DUE. IN SHORT, COMPANIES, WHICH FILE ACCOUNTS THROUGH "LUCRO
PRESUMIDO" PROCEEDING, ARE USUALLY PROFITABLE COMPANIES. |
|
REAL ESTATE: |
NOT AVAILABLE
|
VEHICLES: |
OWNED VEHICLES ARE VALUED AT R$
53.782,86
|
MACHINES: |
OWNED MACHINES AND EQUIPMENTS
ARE VALUED AT R$ 218.476,49
|
NOT AVAILABLE. |
|
|
BRANCH/PHONE: |
|
|
BANCO BRADESCO S/A |
298-4 / 11 3296-0411 |
|
|
BANCO DO BRASIL S/A |
1192-4 |
|
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE
INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW
PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY
HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682
BRAZILIAN CENTRAL BANK"). |
|
THE SUBJECT IS ENGAGED IN THE MANUFACTURE AND SALE OF PHARMACEUTICAL
PRODUCTS. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
INDIA. |
EXPORTS TO:
|
DOES NOT EXPORT. |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC
CLIENTS: |
|
|
|
DIMESUL DISTRIBUIDORA DE MEDICAMENTOS LTDA |
|
|
|
DISNAT DISTRIBUIDORA DE PRODUTOS NATURAIS |
|
|
|
DISTRIBUIDORA NAWARRO LTDA |
|
|
|
STAFF: |
|
|
|
THE COMPANY HAS: 200 EMPLOYEE(S) |
|
THE SUBJECT IS AN OLD AND WELL-ESTABLISHED COMPANY. IT IS FAMILY-OWNED
AND MANAGED BY WELL-EXPERIENCED STAFF. BOTH THE COMPANY AND ITS PRINCIPALS
HAVE A GOOD TRADE REPUTATION AND A CLEAR HISTORY. THE COMPANY HAS TRADE RELATIONS WITH SOME LOCAL SUPPLIERS BUT UP TO
DATE ONLY SMALL PAYMENTS WERE REPORTED AND THE SUBJECT IS NOT SAID TO BE USER
OF TRADE CREDIT FACILITIES. NEVERTHELESS, AS NO PAYMENT DELAYS ARE REGISTERED AND AS NO
DETRIMENTAL RECORDS WERE FOUND IT MAY BE NOTED THAT THE COMPANY MEETS ITS
TRADE AND FINANCIAL COMMITMENTS PROPERLY. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC
SUPPLIERS: |
|
PHONE: |
|
ALLPLAS EMBALAGENS LTDA |
|
11 4612-2233 |
|
BISFARMA IND. DE EMBALAGENS LTDA |
|
19 3893-3544 |
|
CHEMICAL IND. COMÉRCIO E REPRES. LTDA |
|
11 5542-6647 |
|
EMEFARMA RIO REPRESENTACOES LTDA |
|
|
|
ESKISA S/A INDÚSTRIA E COMÉRCIO |
|
11 5536-0533 |
|
FORLAB-CHITEC S/A COMÉRCIO INTERNACIONAL |
|
21 2221-2696 |
|
GIMBA SUPRIMENTOS DE ESCRITORIO E INFORMATICA LTDA |
|
|
|
INDUKERN DO BRASIL QUIMICA LTDA. |
|
|
|
LAWES MÁQUINAS E EQUIPAMENTOS LTDA |
|
11 4178-3311 |
|
LIBRA ARTES GRÁFICA LTDA |
|
11 6966-0949 |
|
MASE PRODUTOS QUÍMICOS E FARMACÊUTICOS LTDA |
|
11 3277-2920 |
|
MEGAMED 1600 DISTRIBUIDORA DE MEDICAMENTOS, PERFUMARIA E COR |
|
|
|
PRINT INDÚSTRIA DE ARTES GRÁFICAS LTDA |
|
11 5667-2933 |
|
TECNOPHARMA IND. COM. DE EMBALAGENS LTDA |
|
11 5679-6514 |
|
VALDEQUIMICA PRODUTOS QUIMICOS LTDA |
|
11 3721-1077 |
|
VEDAT TAMPAS HERMÉTICAS LTDA |
|
11 4704-4266 |
|
PAYMENT HISTORY: |
|
11 SUPPLIERS REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 137.042,00 |
|
|
|
AMOUNT OF INVOICES PAID: 78 |
|
TOTAL OF PROMPT PAYMENTS: 97,9% |
|
TOTAL OF DELAYED PAYMENTS: 2,1% |
|
|
|
HIGHEST INVOICE: R$ 10.028,00 |
|
HIGHEST CREDIT: R$ 10.028,00 |
|
|
|
OUTSTANDING INVOICES DUE WITHIN THE NEXT 60 DAYS: |
|
--------------------------- |
SUPPLIERS: |
INVOICES: |
TOTAL AMOUNT: |
|
DUE WITHIN 30 DAYS |
2 |
2 |
R$ 322,27 |
|
DUE WITHIN 60 DAYS |
1 |
1 |
R$ 116,52 |
|
ALL |
2 |
3 |
R$ 438,79 |
|
THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR OVER 50 YEARS.
THE COMPANY KEEPS OPERATING NORMALLY SO FAR BUT IN THE ABSENCE OF FINANCIAL
DATA WE CANNOT ACCESS ITS CURRENT FINANCIAL STANDING. BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD
TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED BUT IN
MODERATE AMOUNTS ONLY DUE TO THE ABSENCE OF FINANCIAL DATA. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.81 |
|
|
1 |
Rs.86.52 |
|
Euro |
1 |
Rs.69.50 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.